Importantly, increased ABL kinase activity has been detected in lung cancer cells without genomic alterations [13], and inactivation of ABL kinases suppresses lung cancer metastasis following intracardiac injection of NSCLC lines into immune-deficient mice [14]. The gene discussed is ABL1; the disease is non-small cell lung carcinoma.